Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000275027 | SCV000377357 | likely benign | Rotor syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000275027 | SCV001157072 | uncertain significance | Rotor syndrome | 2023-05-26 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000275027 | SCV000044682 | pathogenic | Rotor syndrome | 2012-02-01 | no assertion criteria provided | literature only | |
Prevention |
RCV004757993 | SCV005348015 | uncertain significance | SLCO1B1-related disorder | 2024-08-06 | no assertion criteria provided | clinical testing | The SLCO1B1 c.481+1G>T variant is predicted to disrupt the GT donor site and interfere with normal splicing. This variant was reported in both the heterozygous and compound heterozygous state with a 405 kb deletion (including exons 3-15 of SLCO1B3 and the entire SLCO1B1 gene) in unaffected members of a family with Rotor syndrome (Family A2, van de Steeg et al. 2012. PubMed ID: 22232210). Affected members of Family A2 were homozygous for the 405 kb deletion, demonstrating that only a complete deficiency of both alleles of SLCO1B1 and SLCO1B3 result in Rotor syndrome. In the gnomAD population database, this variant has been reported in 844 heterozygous and 10 homozygous individuals of unknown phenotype. In the ClinVar database, this variant has conflicting interpretations regarding its pathogenicity ranging from likely benign to pathogenic (https://www.ncbi.nlm.nih.gov/clinvar/variation/307938/). At this time, the clinical significance of the c.481+1G>T variant is uncertain due to the absence of conclusive functional and genetic evidence. |